Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon) [Phase 3]

View source ↗

Summary

A randomized, double-blind, placebo-controlled Phase 3 trial evaluating glatiramer acetate effects on retinal nerve fiber layer and visual function in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Optic Neuritis

Drugs mentioned

• GLATIRAMER ACETATE (GLATIRAMER ACETATE)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Optic Neuritis | Phase 3 | Status: COMPLETED | Results posted: 2013-09-23